Detection of EGFR gene mutations for prescription of targeted drugs for non-small cell lung cancer
Lung cancer is one of the most common types of cancer that occurs in both men and women. This tumor is the leading cause of death from cancer, accounting for 18.4% of the total number of deaths. Non-small cell lung cancer is the most common type of lung cancer, accounting for 85% of all cases. Withi...
Saved in:
| Main Authors: | O. N. Pavlova, O. P. Bukareva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2024-04-01
|
| Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
| Subjects: | |
| Online Access: | https://vestnik.reaviz.ru/jour/article/view/912 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker
by: Meejeong Kim, et al.
Published: (2025-04-01) -
Case Report: A Bilateral Synchronous Primary Non‐Small Cell Lung Cancer Patient With Two Different EGFR Mutations
by: Thanh‐Dung Quach, et al.
Published: (2025-08-01) -
Review of Plasma Exosomal DNA for Detecting EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
by: Mohammad Mehdi Jahani, et al.
Published: (2025-04-01) -
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers
by: Jinjing Tan, et al.
Published: (2025-04-01) -
Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study
by: Kaicheng Pan, et al.
Published: (2025-04-01)